Overcoming Data Quality Challenges During COVID-19 Date Published: May 05, 2020 Whitepaper Signant’s Alan Kott discusses how the COVID-19 pandemic brought unique challenges to clinical trial research, especially in terms of patient safety and data validity. From the perspective of data analytics, the impact of pandemic can be broken into 2 broad categories: operational disruptions and direct impact on patients. Quality data concerns include: Partially or missing dataData tampering or data fabricationFrequent changes in raters or assessment modality Download Now Share: LinkedIn0Tweet0 Recommended Resources Site Perspectives on BYOD ePRO Use Download Whitepaper The 4 S’s of eCOA Success Download Now Whitepaper Digital Health Technologies (DHTs) in Clinical Trials: Key Points from the FDA’S Important Draft Guidance Download Now Whitepaper